ID24264A - Komposisi yang terdiri dari 5-[4-[2-(n-metil-n-2-piridil)amino) etoksi[benzil] tiazolidin-2,4-dion - Google Patents

Komposisi yang terdiri dari 5-[4-[2-(n-metil-n-2-piridil)amino) etoksi[benzil] tiazolidin-2,4-dion

Info

Publication number: ID24264A
Authority: ID; Indonesia
Prior art keywords: ethocysie; tiazolidin; dion; benzil; pyridyl
Prior art date: 1997-06-05

Application number

IDW991520A

Other languages

English (en)

Inventor

Jeffrey Roger Granett

Original Assignee

Smithkline Beecham P L C Cs

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-05

Filing date

1998-06-02

Publication date

2000-07-13

1997-06-18 Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en

1998-06-02 Application filed by Smithkline Beecham P L C Cs filed Critical Smithkline Beecham P L C Cs

2000-07-13 Publication of ID24264A publication Critical patent/ID24264A/id

Links

-1 AMINO Chemical class 0.000 title 1
229920004518 DION® Polymers 0.000 title 1
WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical compound C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

IDW991520A 1997-06-05 1998-06-02 Komposisi yang terdiri dari 5-[4-[2-(n-metil-n-2-piridil)amino) etoksi[benzil] tiazolidin-2,4-dion ID24264A (id)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9711683.4A GB9711683D0 (en)	1997-06-05	1997-06-05	Composition
GBGB9712851.6A GB9712851D0 (en)	1997-06-18	1997-06-18	Composition
PCT/EP1998/003478 WO1998055122A1 (en)	1997-06-05	1998-06-02	Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Publications (1)

Publication Number	Publication Date
ID24264A true ID24264A (id)	2000-07-13

Family

ID=26311662

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW991520A ID24264A (id)	1997-06-05	1998-06-02	Komposisi yang terdiri dari 5-[4-[2-(n-metil-n-2-piridil)amino) etoksi[benzil] tiazolidin-2,4-dion

Country Status (29)

Country	Link
EP (1)	EP0998284A1 (id)
JP (1)	JP2001521553A (id)
KR (1)	KR20010013410A (id)
CN (3)	CN1112926C (id)
AP (1)	AP1214A (id)
AR (2)	AR008198A1 (id)
AU (1)	AU8215098A (id)
BG (1)	BG104048A (id)
BR (1)	BR9810405A (id)
CA (2)	CA2333352A1 (id)
CO (1)	CO4940400A1 (id)
DZ (1)	DZ2510A1 (id)
EA (1)	EA002384B1 (id)
GB (1)	GB9711683D0 (id)
HU (1)	HUP0004070A3 (id)
ID (1)	ID24264A (id)
IL (1)	IL133074A0 (id)
MX (1)	MXPA99011322A (id)
NO (2)	NO995938L (id)
NZ (2)	NZ523725A (id)
OA (1)	OA11306A (id)
PE (1)	PE78899A1 (id)
PL (1)	PL337201A1 (id)
SK (1)	SK164899A3 (id)
TR (2)	TR200002790T2 (id)
TW (1)	TW570797B (id)
UY (1)	UY25032A1 (id)
WO (1)	WO1998055122A1 (id)
ZA (2)	ZA984826B (id)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
AR023561A1 (es) *	1999-04-23	2002-09-04	Smithkline Beecham Corp	Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento
HRP20010773B1 (en)	1999-04-23	2005-06-30	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
GB0021978D0 (en)	2000-09-07	2000-10-25	Smithkline Beecham Plc	Novel pharmaceutical
GB0127805D0 (en) *	2001-11-20	2002-01-09	Smithkline Beecham Plc	Pharmaceutical composition
WO2003050112A1 (en) *	2001-12-13	2003-06-19	Smithkline Beecham Plc	Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0129871D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0130509D0 (en) *	2001-12-20	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
US7435741B2 (en)	2006-05-09	2008-10-14	Teva Pharmaceutical Industries, Ltd.	2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
ES2294980T1 (es) *	2006-05-09	2008-04-16	Teva Pharmaceutical Industries Ltd.	Acido 2-n-(5-((4-(2-(metil-2-piridinilamino)etoxi)fenil)metil)-2,4-tiazolidindiona)-butanodioico, procedimientos de preparacion y composiciones con maleato de rosiglitazona.
WO2015008234A1 (en) *	2013-07-17	2015-01-22	Glenmark Pharmaceuticals S.A.	Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE186724T1 (de) *	1987-09-04	1999-12-15	Beecham Group Plc	Substituierte thiazolidindionderivate
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
WO1995021608A1 (en) *	1994-02-10	1995-08-17	Smithkline Beecham Plc	Use of insulin sensitisers for treating renal diseases
JPH11510508A (ja) *	1995-08-10	1999-09-14	ワーナー−ランバート・コンパニー	インシュリン非依存性真性糖尿病患者に投与される外来インシュリンの量を減らす方法
WO1997018811A1 (en) *	1995-11-17	1997-05-29	Warner-Lambert Company	A method of treating myotonic dystrophy
NZ314406A (en) *	1996-03-18	2000-12-22	Sankyo Co	Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
AU3552697A (en) *	1996-07-12	1998-02-09	Smithkline Beecham Plc	Novel treatment of leptine resistance

1997
- 1997-06-05 GB GBGB9711683.4A patent/GB9711683D0/en active Pending
1998
- 1998-06-02 SK SK1648-99A patent/SK164899A3/sk unknown
- 1998-06-02 CA CA002333352A patent/CA2333352A1/en not_active Abandoned
- 1998-06-02 BR BR9810405-5A patent/BR9810405A/pt not_active IP Right Cessation
- 1998-06-02 PL PL98337201A patent/PL337201A1/xx unknown
- 1998-06-02 CA CA002292629A patent/CA2292629C/en not_active Expired - Fee Related
- 1998-06-02 EA EA199901116A patent/EA002384B1/ru not_active IP Right Cessation
- 1998-06-02 WO PCT/EP1998/003478 patent/WO1998055122A1/en not_active Ceased
- 1998-06-02 TR TR2000/02790T patent/TR200002790T2/xx unknown
- 1998-06-02 KR KR19997011411A patent/KR20010013410A/ko not_active Ceased
- 1998-06-02 EP EP98932144A patent/EP0998284A1/en not_active Withdrawn
- 1998-06-02 JP JP50158799A patent/JP2001521553A/ja not_active Ceased
- 1998-06-02 AP APAP/P/1999/001696A patent/AP1214A/en active
- 1998-06-02 TR TR1999/02963T patent/TR199902963T2/xx unknown
- 1998-06-02 MX MXPA99011322A patent/MXPA99011322A/es unknown
- 1998-06-02 IL IL13307498A patent/IL133074A0/xx unknown
- 1998-06-02 CN CN98805686A patent/CN1112926C/zh not_active Expired - Lifetime
- 1998-06-02 CN CNA2003101199090A patent/CN1526391A/zh active Pending
- 1998-06-02 NZ NZ523725A patent/NZ523725A/en unknown
- 1998-06-02 AU AU82150/98A patent/AU8215098A/en not_active Abandoned
- 1998-06-02 HU HU0004070A patent/HUP0004070A3/hu unknown
- 1998-06-02 ID IDW991520A patent/ID24264A/id unknown
- 1998-06-03 DZ DZ980120A patent/DZ2510A1/xx active
- 1998-06-04 AR ARP980102649A patent/AR008198A1/es not_active Application Discontinuation
- 1998-06-04 AR ARP980102650A patent/AR015120A1/es not_active Application Discontinuation
- 1998-06-04 CO CO98031614A patent/CO4940400A1/es unknown
- 1998-06-04 UY UY25032A patent/UY25032A1/es not_active IP Right Cessation
- 1998-06-04 ZA ZA9804826A patent/ZA984826B/xx unknown
- 1998-06-04 ZA ZA9811572A patent/ZA9811572B/xx unknown
- 1998-06-05 PE PE1998000466A patent/PE78899A1/es not_active Application Discontinuation
- 1998-10-23 TW TW087117536A patent/TW570797B/zh not_active IP Right Cessation
1999
- 1999-12-02 OA OA9900267A patent/OA11306A/en unknown
- 1999-12-03 NO NO995938A patent/NO995938L/no not_active Application Discontinuation
- 1999-12-27 BG BG104048A patent/BG104048A/bg unknown
2001
- 2001-09-03 NZ NZ513922A patent/NZ513922A/xx unknown
2002
- 2002-11-05 CN CN02149972A patent/CN1430959A/zh active Pending
2004
- 2004-02-20 NO NO20040738A patent/NO20040738L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2292629C (en)	2004-01-06
MXPA99011322A (es)	2004-12-02
BG104048A (bg)	2000-07-31
EA002384B1 (ru)	2002-04-25
NO20040738L (no)	2000-02-02
EA199901116A1 (ru)	2000-06-26
NO995938D0 (no)	1999-12-03
NO995938L (no)	2000-02-02
AR015120A1 (es)	2001-04-18
NZ513922A (en)	2001-09-28
AR008198A1 (es)	1999-12-29
TW570797B (en)	2004-01-11
AU8215098A (en)	1998-12-21
WO1998055122A1 (en)	1998-12-10
BR9810405A (pt)	2000-08-29
JP2001521553A (ja)	2001-11-06
KR20010013410A (ko)	2001-02-26
CN1259050A (zh)	2000-07-05
NZ523725A (en)	2004-09-24
HUP0004070A2 (hu)	2002-02-28
CA2292629A1 (en)	1998-12-10
CN1526391A (zh)	2004-09-08
PL337201A1 (en)	2000-08-14
CA2333352A1 (en)	1998-12-10
GB9711683D0 (en)	1997-08-06
CN1112926C (zh)	2003-07-02
ZA984826B (en)	1999-08-03
TR200002790T2 (tr)	2001-11-21
CO4940400A1 (es)	2000-07-24
HUP0004070A3 (en)	2002-03-28
IL133074A0 (en)	2001-03-19
TR199902963T2 (xx)	2000-02-21
DZ2510A1 (fr)	2003-01-25
PE78899A1 (es)	1999-10-22
OA11306A (en)	2003-10-22
ZA9811572B (en)	1999-07-22
CN1430959A (zh)	2003-07-23
AP1214A (en)	2003-10-08
SK164899A3 (en)	2000-11-07
AP9901696A0 (en)	1999-12-31
EP0998284A1 (en)	2000-05-10
UY25032A1 (es)	1998-11-26

Publication	Publication Date	Title
DE69718480D1 (de)	2003-02-20	Heterocyclische metalloprotease inhibitoren
ATE226573T1 (de)	2002-11-15	Heterozyklische metalloproteaseinhibitoren
ATE267805T1 (de)	2004-06-15	Lactamverbindungen als metalloprotease- inhibitoren
ATE443055T1 (de)	2009-10-15	Inhibitoren der 11-beta-hydroxy-steroid- dehydrogenase des typs 1
ATE417828T1 (de)	2009-01-15	Heterocyclische inhibitoren von p38
NO20021116D0 (no)	2002-03-06	Ny sammensetning
DE69830410D1 (de)	2005-07-07	Meta-benzamidinderivate als serinprotease-inhibitoren
DK1114051T3 (da)	2003-07-14	Inhibitorer for p38
MA26500A1 (fr)	2004-12-20	Forme nouvelle de s-omerprazole
NO990548L (no)	1999-04-07	Inhibitorer for cystein-protease
NO20020307D0 (no)	2002-01-21	N-(indolkarbonyl)piperazinderivater
NO20021115L (no)	2002-04-30	Ny sammensetning
DE60009675D1 (de)	2004-05-13	Protonenpumpinhibitoren enthaltende zusammensetzung
ATE333866T1 (de)	2006-08-15	Lipasehemmer enthaltende dispersionsformulierungen
DK0928291T3 (da)	2003-03-17	3-Mercaptoacetylamino-1,5-substituerede 2-oxo-azepanderivater, der er nyttige som inhibitorer af matrixmetalloproteinase
AP9901696A0 (en)	1999-12-31	Composition comprising 5-(4-(2-(N-methyl-N-2-pyridyl)amino) ehtoxy benzyl)thiazolidine-2,4-dione
ID24267A (id)	2000-07-13	Enansiomer-enansiomer dari 4-[[(sianoimino) [(1,2,2-trimetilpropil) amino] metil] amino] benzonitril
DK199901730A (da)	2000-12-23	Ny Sammensætning
DK0928192T3 (da)	2002-08-19	Antimykotisk gel med høj frigivelse af aktivt stof
BR9710322A (pt)	1999-08-17	Tioamidas N-(5-isotiazolil) substituidas
DK0888340T3 (da)	2002-11-04	4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carboxylsyre-derivater som antagonister for enodthelin
ATE525362T1 (de)	2011-10-15	2-(3-(4-(2-t-butyl-6-trifluormethylpyrimidin-4-
ID24081A (id)	2000-07-06	Senyawa-senyawa 5-(2-imidazolinilamino) benzimidazol yang berguna sebagai agonis-agonis alfa-2-adrenoseptor
DK0944601T3 (da)	2003-06-10	Heterocykliske quanidinylaminoforbindelser som alfa-2-adrenoceptoragonister
DK1150976T3 (da)	2003-06-02	3-(Thiosubstituerede amido)lactamer, der er nyttige som inhibitorer af matrixmetalloproteinase